MINI REVIEW
Accepted on 10 Nov 2025
Engineering with Care: Safety Assessment Platforms for CRISPR-Modified Natural Killer cells
- 442 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Safety and efficacy of CRISPR/Cas-based genome editing tools: applications and considerations in cell and gene therapy
Safety and efficacy of CRISPR/Cas-based genome editing tools: applications and considerations in cell and gene therapy
9,824
Total downloads
47k
Total views and downloads
Articles
PERSPECTIVE
Published on 16 May 2025
Strategies for CRISPR-based knock-ins in primary human B cells and lymphoma cell lines
doi 10.3389/fimmu.2025.1589729
- 3,952 views
REVIEW
Published on 29 Sep 2020
CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
doi 10.3389/fimmu.2020.02062
- 29,830 views
- 65 citations
ORIGINAL RESEARCH
Published on 12 Nov 2018
Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2
doi 10.3389/fimmu.2018.02595
- 7,365 views
- 24 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
T Cell Biology
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore